Applicability of the CT Radiomics of Skeletal Muscle and Machine Learning for the Detection of Sarcopenia and Prognostic Assessment of Disease Progression in Patients with Gastric and Esophageal Tumors

Daniel Vogele,Teresa Mueller,Daniel Wolf,Stephanie Otto,Sabitha Manoj,Michael Goetz,Thomas J. Ettrich,Meinrad Beer

DOI: https://doi.org/10.3390/diagnostics14020198

IF: 3.6

2024-01-17

Diagnostics

Abstract:Purpose: Sarcopenia is considered a negative prognostic factor in patients with malignant tumors. Among other diagnostic options, computed tomography (CT), which is repeatedly performed on tumor patients, can be of further benefit. The present study aims to establish a framework for classifying the impact of sarcopenia on the prognosis of patients diagnosed with esophageal or gastric cancer. Additionally, it explores the significance of CT radiomics in both diagnostic and prognostic methodologies. Materials and Methods: CT scans of 83 patients with esophageal or gastric cancer taken at the time of diagnosis and during a follow-up period of one year were evaluated retrospectively. A total of 330 CT scans were analyzed. Seventy three of these patients received operative tumor resection after neoadjuvant chemotherapy, and 74% of the patients were male. The mean age was 64 years (31–83 years). Three time points (t) were defined as a basis for the statistical analysis in order to structure the course of the disease: t1 = initial diagnosis, t2 = following (neoadjuvant) chemotherapy and t3 = end of the first year after surgery in the "surgery" group or end of the first year after chemotherapy. Sarcopenia was determined using the psoas muscle index (PMI). The additional analysis included the analysis of selected radiomic features of the psoas major, quadratus lumborum, and erector spinae muscles at the L3 level. Disease progression was monitored according to the response evaluation criteria in solid tumors (RECIST 1.1). CT scans and radiomics were used to assess the likelihood of tumor progression and their correlation to sarcopenia. For machine learning, the established algorithms decision tree (DT), K-nearest neighbor (KNN), and random forest (RF) were applied. To evaluate the performance of each model, a 10-fold cross-validation as well as a calculation of Accuracy and Area Under the Curve (AUC) was used. Results: During the observation period of the study, there was a significant decrease in PMI. This was most evident in patients with surgical therapy in the comparison between diagnosis and after both neoadjuvant therapy and surgery (each p < 0.001). Tumor progression (PD) was not observed significantly more often in the patients with sarcopenia compared to those without sarcopenia at any time point (p = 0.277 to p = 0.465). On average, PD occurred after 271.69 ± 104.20 days. The time from initial diagnosis to PD in patients "with sarcopenia" was not significantly shorter than in patients "without sarcopenia" at any of the time points (p = 0.521 to p = 0.817). The CT radiomics of skeletal muscle could predict both sarcopenia and tumor progression, with the best results for the psoas major muscle using the RF algorithm. For the detection of sarcopenia, the Accuracy was 0.90 ± 0.03 and AUC was 0.96 ± 0.02. For the prediction of PD, the Accuracy was 0.88 ± 0.04 and the AUC was 0.93 ± 0.04. Conclusions: In the present study, the CT radiomics of skeletal muscle together with machine learning correlated with the presence of sarcopenia, and this can additionally assist in predicting disease progression. These features can be classified as promising alternatives to conventional methods, with great potential for further research and future clinical application. However, when sarcopenia was diagnosed with PMI, no significant correlation between sarcopenia and PD could be observed.

medicine, general & internal

What problem does this paper attempt to address?

The problems that this paper attempts to solve are:

1. **The impact of sarcopenia on the prognosis of patients with gastric cancer and esophageal cancer**: Sarcopenia is considered as a negative prognostic factor for patients with malignant tumors. The paper aims to establish a framework for classifying the prognostic impact of sarcopenia on patients diagnosed with esophageal or gastric cancer.

2. **The application of CT radiomics and machine learning in diagnosis and prediction**: In addition, the paper also explores the importance of CT radiomics in diagnosis and prognostic methods, especially detecting sarcopenia and predicting disease progression through CT radiomics and machine - learning techniques.

Specifically, the main objectives of the study include:
- **Evaluating the relationship between sarcopenia and tumor progression**: By analyzing CT image data, study whether sarcopenia will affect the disease progression of patients with gastric cancer and esophageal cancer.
- **Developing a prediction model based on CT radiomics and machine learning**: Use CT radiomics features and machine - learning algorithms (such as decision trees, K - nearest neighbors and random forests) to predict sarcopenia and tumor progression.

The research methods include:
- **Retrospective analysis of CT scan data**: Conduct a retrospective analysis of 330 CT scans of 83 patients with gastric cancer and esophageal cancer.
- **Definition and evaluation of sarcopenia**: Use the psoas muscle index (PMI) to define and evaluate sarcopenia.
- **Radiomics feature extraction**: Extract radiomics features of skeletal muscles from CT images and analyze them using machine - learning algorithms.
- **Statistical analysis**: Use statistical methods such as Fisher's exact test and Mann - Whitney U test to evaluate the relationship between sarcopenia and tumor progression.

The conclusions of the study are:
- **CT radiomics combined with machine learning can effectively detect sarcopenia and predict tumor progression**: Especially when using the random forest algorithm, the accuracy rate of detecting sarcopenia is 0.90 ± 0.03, and the AUC is 0.96 ± 0.02; the accuracy rate of predicting tumor progression is 0.88 ± 0.04, and the AUC is 0.93 ± 0.04.
- **There is no significant correlation between sarcopenia and tumor progression**: Although CT radiomics and machine learning can effectively predict sarcopenia and tumor progression, there is no significant correlation between sarcopenia diagnosed by PMI and tumor progression.

These results indicate that CT radiomics and machine learning have potential application value in the diagnosis and prediction of sarcopenia and tumor progression, but further research is needed to verify their clinical practicality.